First-in-human clinical data on Mttp inhibitor JNJ-16269110 presented at ASCPT meeting March 25, 2010
ONCOFID-P-B well tolerated and active in phase I trial in refractory bladder carcinoma March 25, 2010
Persistent antibody response noted in adolescents 2 years after vaccination with Men ACWY March 24, 2010
RSS